244 related articles for article (PubMed ID: 28825924)
1. Radical prostatectomy in oligometastatic prostate cancer.
Mandel P; Steuber T; Graefen M
Curr Opin Urol; 2017 Nov; 27(6):572-579. PubMed ID: 28825924
[TBL] [Abstract][Full Text] [Related]
2. Role of radical prostatectomy in metastatic prostate cancer: A review.
Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
[TBL] [Abstract][Full Text] [Related]
3. [Surgical treatment of local disease in metastatic prostate cancer.].
Gaya JM; Huguet J; Breda A; Palou J
Arch Esp Urol; 2018 Mar; 71(3):288-297. PubMed ID: 29633950
[TBL] [Abstract][Full Text] [Related]
4. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
6. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.
Kunz I; Musch M; Roggenbuck U; Klevecka V; Kroepfl D
BJU Int; 2013 Mar; 111(3 Pt B):E24-9. PubMed ID: 22947135
[TBL] [Abstract][Full Text] [Related]
7. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
8. A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.
Sooriakumaran P; Karnes J; Stief C; Copsey B; Montorsi F; Hammerer P; Beyer B; Moschini M; Gratzke C; Steuber T; Suardi N; Briganti A; Manka L; Nyberg T; Dutton SJ; Wiklund P; Graefen M
Eur Urol; 2016 May; 69(5):788-94. PubMed ID: 26038098
[TBL] [Abstract][Full Text] [Related]
9. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
Kim J; Park JS; Ham WS
Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?
Marenco J; Sooriakumaran P
Arch Esp Urol; 2019 Mar; 72(2):174-181. PubMed ID: 30855019
[TBL] [Abstract][Full Text] [Related]
11. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
12. Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy.
Beyer B; Mandel P; Michl U; Pompe RS; Veleva V; Steuber T; Huland H; Graefen M; Tilki D
World J Urol; 2016 Aug; 34(8):1101-5. PubMed ID: 26757719
[TBL] [Abstract][Full Text] [Related]
13. Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases?
Jang WS; Kim MS; Jeong WS; Chang KD; Cho KS; Ham WS; Rha KH; Hong SJ; Choi YD
BJU Int; 2018 Feb; 121(2):225-231. PubMed ID: 28834084
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M
Urologia; 2014; 81(2):125-32. PubMed ID: 24474543
[TBL] [Abstract][Full Text] [Related]
15. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
[TBL] [Abstract][Full Text] [Related]
16. [Radical prostatectomy in locally advanced prostate cancer].
Mandel P; Tilki D; Graefen M
Urologe A; 2017 Nov; 56(11):1394-1401. PubMed ID: 28983643
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature.
Ruiz Aragón J; Jiménez Varo E; Ruiz Aragón AI; Revelo Cadena I; Agüera Sánchez Á; Jiménez Romero ME
Actas Urol Esp (Engl Ed); 2023; 47(6):332-340. PubMed ID: 36319558
[TBL] [Abstract][Full Text] [Related]
18. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
19. Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
Steuber T; Berg KD; Røder MA; Brasso K; Iversen P; Huland H; Tiebel A; Schlomm T; Haese A; Salomon G; Budäus L; Tilki D; Heinzer H; Graefen M; Mandel P
Eur Urol Focus; 2017 Dec; 3(6):646-649. PubMed ID: 28753877
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.
Berglund RK; Jones JS; Ulchaker JC; Fergany A; Gill I; Kaouk J; Klein EA
Urology; 2006 Jun; 67(6):1253-6. PubMed ID: 16678888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
